DK0729457T3 - Diaminocyclobuten-3,4-dioner som afslapningsmidler for glat muskulatur - Google Patents

Diaminocyclobuten-3,4-dioner som afslapningsmidler for glat muskulatur

Info

Publication number
DK0729457T3
DK0729457T3 DK95901739T DK95901739T DK0729457T3 DK 0729457 T3 DK0729457 T3 DK 0729457T3 DK 95901739 T DK95901739 T DK 95901739T DK 95901739 T DK95901739 T DK 95901739T DK 0729457 T3 DK0729457 T3 DK 0729457T3
Authority
DK
Denmark
Prior art keywords
alkyl
smooth muscle
relaxants
diaminocyclobutene
dione
Prior art date
Application number
DK95901739T
Other languages
Danish (da)
English (en)
Inventor
Schuyler Adam Antane
John Anthony Butera
Original Assignee
American Home Prod
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Home Prod filed Critical American Home Prod
Application granted granted Critical
Publication of DK0729457T3 publication Critical patent/DK0729457T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/02—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C07C255/49—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C255/58—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and singly-bound nitrogen atoms, not being further bound to other hetero atoms, bound to the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/30—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/37—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
    • C07C311/38—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring having sulfur atoms of sulfonamide groups and amino groups bound to carbon atoms of six-membered rings of the same carbon skeleton
    • C07C311/43—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring having sulfur atoms of sulfonamide groups and amino groups bound to carbon atoms of six-membered rings of the same carbon skeleton having the nitrogen atom of at least one of the sulfonamide groups bound to a carbon atom of a ring other than a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38—Nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38—Nitrogen atoms
    • C07D215/40—Nitrogen atoms attached in position 8
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/54—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
    • C07D231/56—Benzopyrazoles; Hydrogenated benzopyrazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/04—Systems containing only non-condensed rings with a four-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/36—Systems containing two condensed rings the rings having more than two atoms in common
    • C07C2602/42—Systems containing two condensed rings the rings having more than two atoms in common the bicyclo ring system containing seven carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Pens And Brushes (AREA)
  • Polyoxymethylene Polymers And Polymers With Carbon-To-Carbon Bonds (AREA)
  • Pyridine Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DK95901739T 1993-11-17 1994-11-01 Diaminocyclobuten-3,4-dioner som afslapningsmidler for glat muskulatur DK0729457T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/153,706 US5354763A (en) 1993-11-17 1993-11-17 Substituted N-heteroaryl and N-aryl-1,2-diaminocyclobutene-3,4-diones
PCT/US1994/012561 WO1995014005A1 (en) 1993-11-17 1994-11-01 Diaminocyclobutene-3,4-diones as smooth muscle relaxants

Publications (1)

Publication Number Publication Date
DK0729457T3 true DK0729457T3 (da) 1999-08-23

Family

ID=22548391

Family Applications (1)

Application Number Title Priority Date Filing Date
DK95901739T DK0729457T3 (da) 1993-11-17 1994-11-01 Diaminocyclobuten-3,4-dioner som afslapningsmidler for glat muskulatur

Country Status (22)

Country Link
US (5) US5354763A (lv)
EP (1) EP0729457B1 (lv)
JP (1) JPH09505296A (lv)
KR (1) KR960705780A (lv)
AT (1) ATE174907T1 (lv)
AU (1) AU677479B2 (lv)
CA (1) CA2175386A1 (lv)
DE (1) DE69415554T2 (lv)
DK (1) DK0729457T3 (lv)
ES (1) ES2126241T3 (lv)
FI (1) FI962070A (lv)
GR (1) GR3029646T3 (lv)
HK (1) HK1011353A1 (lv)
HU (1) HU215603B (lv)
IL (1) IL111529A (lv)
LV (1) LV12258B (lv)
NZ (1) NZ276568A (lv)
PH (1) PH31054A (lv)
SG (1) SG47587A1 (lv)
SI (1) SI0729457T1 (lv)
WO (1) WO1995014005A1 (lv)
ZA (1) ZA948877B (lv)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5466712A (en) * 1994-11-04 1995-11-14 American Home Products Corporation Substituted n-aryl-1,2-diaminocyclobutene-3,4-diones
ES2128774T3 (es) * 1994-11-16 1999-05-16 American Home Prod Diaminociclobuten-3,4-dionas.
US5464867A (en) * 1994-11-16 1995-11-07 American Home Products Corporation Diaminocyclobutene-3,4-diones
CN1227543A (zh) * 1996-06-17 1999-09-01 美国家用产品公司 作为钾通道调节剂的环丁烯－3,4－二酮的杂环甲基氨基衍生物
US5872139A (en) * 1996-06-17 1999-02-16 American Home Products Corporation Heterocyclymethylamino derivatives of cyclobutene-3,4-diones
US5846999A (en) * 1996-07-17 1998-12-08 American Home Products Corporation Substituted N-arylmethylamino derivatives of cyclobutene-3,4-diones
US5780505A (en) * 1996-07-17 1998-07-14 American Home Products Corporation Substituted N-arylmethylamino derivatives of cyclobutene-3, 4-diones
US5763474A (en) * 1996-07-17 1998-06-09 American Home Products Corporation Substituted N-arylmethylamino derivatives of cyclobutene-3,4-diones
US5750574A (en) * 1996-07-17 1998-05-12 American Home Products Corporation Fluorinated N-arylmethylamino derivatives of cyclobutene-3,4-diones
US5840764A (en) * 1997-01-30 1998-11-24 American Home Products Corporation Substituted hydroxy-anilino derivatives of cyclobutene-3,4-diones
WO1998033763A1 (en) * 1997-01-30 1998-08-06 American Home Products Corporation Substituted hydroxy-anilino derivatives of cyclobutene-3,4-diones
US6376555B1 (en) 1998-12-04 2002-04-23 American Home Products Corporation 4-substituted-3-substituted-amino-cyclobut-3-ene-1,2-diones and analogs thereof as novel potassium channel openers
BR9915899A (pt) * 1998-12-04 2001-08-21 American Home Prod Composto, composição farmacêutica e método para tratar ou inibir distúrbios associados com contração do músculo liso.
WO2001038329A1 (fr) * 1999-11-24 2001-05-31 Sumika Fine Chemicals Co., Ltd. Cristaux de mirtazapine anhydre et leur procede d'obtention
US20030204085A1 (en) * 2001-02-02 2003-10-30 Taveras Arthur G. 3, 4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor antagonists
US6495576B2 (en) 2001-02-07 2002-12-17 Abbott Laboratories Aminal diones as potassium channel openers
US20040106794A1 (en) * 2001-04-16 2004-06-03 Schering Corporation 3,4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands
SK287598B6 (sk) * 2001-04-16 2011-03-04 Schering Corporation 3,4-Disubstituované cyklobutén-1,2-dióny, farmaceutický prostriedok s ich obsahom a ich použitie
US7132445B2 (en) * 2001-04-16 2006-11-07 Schering Corporation 3,4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands
JP2005505595A (ja) * 2001-10-12 2005-02-24 シェーリング　コーポレイション Ｃｘｃ−ケモカインレセプターアンタゴニストとしての３，４−二置換マレイミド化合物
US6878709B2 (en) * 2002-01-04 2005-04-12 Schering Corporation 3,4-di-substituted pyridazinediones as CXC chemokine receptor antagonists
CA2479126C (en) * 2002-03-18 2011-11-15 Schering Corporation Combination treatments for chemokine-mediated diseases
ATE422203T1 (de) * 2002-10-09 2009-02-15 Schering Corp Thiadiazoldioxide und thiadiazoloxide als cxc- und cc-chemokinrezeptor liganden
DE602004016211D1 (en) * 2003-12-19 2008-10-09 Schering Corp Thiadiazole als cxc- und cc-chemokinrezeptorliganden
CA2550540A1 (en) * 2003-12-22 2005-07-28 Schering Corporation Isothiazole dioxides as cxc- and cc- chemokine receptor ligands
EP2096107A1 (en) 2004-12-23 2009-09-02 GPC Biotech AG Derivatives of squaric acid with anti-proliferative activity
CA2613607A1 (en) * 2005-06-29 2007-01-04 Schering Corporation Di-substituted oxadiazoles as cxc-chemokine receptor ligands
US7897606B2 (en) * 2005-06-29 2011-03-01 Schering Corporation 5,6-di-substituted oxadiazolopyrazines and thiadiazolopyrazines as CXC-chemokine receptor ligands
US7956185B2 (en) * 2006-05-26 2011-06-07 Abbott Laboratories Cyclobut-3-ene-1,2,-dione inhibitors of polo-like kinases
AR061829A1 (es) * 2006-07-07 2008-09-24 Schering Corp Ciclobuten-1, 2-dionas 3,4-di sustituidas como ligandos de receptores de quimiocinas cxc
US8450348B2 (en) 2007-02-21 2013-05-28 Forma Tm, Llc Derivatives of squaric acid with anti-proliferative activity
CA2728806A1 (en) 2008-06-24 2009-12-30 Topotarget A/S Squaric acid derivatives as inhibitors of the nicotinamide phosphoribosyltransferase
UA103198C2 (en) * 2008-08-04 2013-09-25 Новартис Аг Squaramide derivatives as cxcr2 antagonists
US9140220B2 (en) 2011-06-30 2015-09-22 Lg Fuel Cell Systems Inc. Engine systems and methods of operating an engine
US8597841B2 (en) 2009-09-04 2013-12-03 Lg Fuel Cell Systems Inc. Method for generating a gas which may be used for startup and shutdown of a fuel cell
US8668752B2 (en) * 2009-09-04 2014-03-11 Rolls-Royce Fuel Cell Systems (Us) Inc. Apparatus for generating a gas which may be used for startup and shutdown of a fuel cell
US9178235B2 (en) 2009-09-04 2015-11-03 Lg Fuel Cell Systems, Inc. Reducing gas generators and methods for generating a reducing gas
US9083020B2 (en) 2009-09-04 2015-07-14 Lg Fuel Cell Systems Inc. Reducing gas generators and methods for generating reducing gas
US9874158B2 (en) 2009-09-04 2018-01-23 Lg Fuel Cell Systems, Inc Engine systems and methods of operating an engine
US9118048B2 (en) 2009-09-04 2015-08-25 Lg Fuel Cell Systems Inc. Engine systems and methods of operating an engine
US8889730B2 (en) 2012-04-10 2014-11-18 Pfizer Inc. Indole and indazole compounds that activate AMPK
CA2905242C (en) 2013-03-15 2016-11-29 Pfizer Inc. Indole compounds that activate ampk
BR112020003245A2 (pt) 2017-08-14 2020-08-18 Allergan, Inc. 3-ciclobuteno-1,2-dionas 3,4-dissubstituído e uso do mesmo
CN116874466A (zh) 2018-09-21 2023-10-13 辉瑞公司 用作ccr6抑制剂的n-取代二氧代环丁烯基氨基-3-羟基-吡啶甲酰胺

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4390701A (en) * 1981-05-18 1983-06-28 Bristol-Myers Company 1-Amino-2-[3-(3-piperidinomethylphenoxy)propylamino]cyclobutene-3,4-dione
JPS60255756A (ja) * 1984-06-01 1985-12-17 Ikeda Mohandou:Kk アミノアルキルフエノキシ誘導体
US5011837A (en) * 1988-08-09 1991-04-30 E. R. Squibb & Sons, Inc. Aryl cyanoguanidines: potassium channel activators and method of making same
ES2088895T3 (es) * 1988-09-16 1996-10-01 Beecham Group Plc Derivados de benzopirano con actividad antihipertensora.
GB8924373D0 (en) * 1989-10-30 1989-12-20 Beecham Group Plc Novel compounds
US5212283A (en) * 1992-03-03 1993-05-18 The United States Of America As Represented By The Administrator Of The National Aeronautics And Space Administration Polyimides containing the cyclobutene-3, 4-dione moiety
JPH0692915A (ja) * 1992-07-28 1994-04-05 Sumitomo Metal Ind Ltd １，２−ジアミノシクロブテン−３，４−ジオン誘導体及びその用途

Also Published As

Publication number Publication date
DE69415554D1 (de) 1999-02-04
EP0729457B1 (en) 1998-12-23
HUT75655A (en) 1997-05-28
HU215603B (hu) 1999-01-28
EP0729457A1 (en) 1996-09-04
FI962070A0 (fi) 1996-05-15
US5397790A (en) 1995-03-14
HK1011353A1 (en) 1999-07-09
LV12258B (lv) 1999-09-20
KR960705780A (ko) 1996-11-08
US5354763A (en) 1994-10-11
AU1086695A (en) 1995-06-06
NZ276568A (en) 1996-11-26
DE69415554T2 (de) 1999-05-12
LV12258A (lv) 1999-04-20
FI962070A (fi) 1996-05-15
ES2126241T3 (es) 1999-03-16
PH31054A (en) 1998-02-03
GR3029646T3 (en) 1999-06-30
US5403854A (en) 1995-04-04
IL111529A (en) 1999-08-17
ZA948877B (en) 1996-05-09
SI0729457T1 (en) 1999-04-30
US5403853A (en) 1995-04-04
CA2175386A1 (en) 1995-05-26
HU9601310D0 (en) 1996-07-29
AU677479B2 (en) 1997-04-24
JPH09505296A (ja) 1997-05-27
IL111529A0 (en) 1995-01-24
WO1995014005A1 (en) 1995-05-26
SG47587A1 (en) 1998-04-17
ATE174907T1 (de) 1999-01-15
US5401753A (en) 1995-03-28

Similar Documents

Publication Publication Date Title
DK0729457T3 (da) Diaminocyclobuten-3,4-dioner som afslapningsmidler for glat muskulatur
NZ296442A (en) N-aryl and N-heteroaryl-1,2-diaminocyclobutene-3,4-diones and use as muscle relaxants
CA2088840A1 (en) 4-benzoyl isoxazole herbicides
ES2139933T3 (es) 2,3-dihidro-1-(2,2,2-trifluoroetil)-2-oxo-5-fenil-1h-1,4-benzodiacepinas.
DE69507639T2 (de) Diaminocyclobuten-3,4-dione
TR21379A (tr) N-fenilpirazol t*revleri
IL92341A0 (en) 2-(2',3',4'-trisubstituted benzoyl)-1,3-cyclohexanediones and their use as herbicides
SE8302824D0 (sv) New herbicidal compounds
DK428087A (da) Dihydropyridin-5-phosphonsyre-cyclopropylenester
ES8801542A1 (es) Procedimiento para preparar compuestos arilsulfonicos.
AR011771A1 (es) Derivados de aminofenil cetona y procedimientos para la preparacion de los mismos
ZA894505B (en) Aminomethylphenols and fungicides containing these compounds